TFG Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

TFG Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-202,887	Closed	-$611K	–	45
2019 Q3	$611K	Buy	+202,887	New	+$628K	0.11%	41

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

TFG Asset Management's LXRX Position: Q4 2019 in Review

TFG Asset Management sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2019, closing a stake of 202,887 shares — an estimated $611K sold.

TFG Asset Management first reported a position in LXRX in Q3 2019 and held it in 1 quarter. The position peaked at $611K in Q3 2019. 115 funds tracked by Wall St. Rank hold LXRX as of Q4 2019.

TFG Asset Management reported no remaining Lexicon Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
TFG Asset Management sold 202,887 Lexicon Pharmaceuticals shares in Q4 2019, an estimated $611K.
TFG Asset Management first reported a position in Lexicon Pharmaceuticals in Q3 2019 and held it in 1 quarter.
TFG Asset Management's Lexicon Pharmaceuticals position peaked at $611K in Q3 2019.
115 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2019.

Based on TFG Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.